Real-time infectious disease outbreak investigations with nanopore sequencing and BugSeq analysis

April 11 2024, 3:00 PM - 4:00 PM BST

Webinar overview

Infectious disease outbreaks continue to pose significant challenges to public health, and solutions are needed that enable real-time, comprehensive genomic characterisation of pathogens and antimicrobial resistance.

In this webinar, we will hear from medical microbiologists sharing their experiences detecting and tracking bacterial outbreaks by implementing real-time sequencing with Oxford Nanopore and analysis with BugSeq, as an end to end solution. Discover how rapid, accessible sequencing and analysis in microbiology laboratories enables swift and accurate investigation of bacterial community clusters, antimicrobial resistance profiling, and contributes to outbreak management.

Please note, this webinar will be broadcast at 3pm (BST)/10am (EST)

Register below to join our webinar, more details coming soon!

Register

Meet the speakers

picture of Christopher Lowe

Sequencing in a clinical microbiology laboratory to investigate a community cluster of Shigella sonnei

Christopher Lowe , Medical Microbiologist, Providence Health Care

Dr. Lowe completed medical school at the University of British Columbia, and residency in Medical Mi...

picture of Sherif Nour

Sherif Nour, Director of Sales & Marketing, BugSeq

Sherif leads Sales and Customer Success with BugSeq. His main focus is in enabling labs to adopt and...

picture of Gordon Ritchie

Sequencing in a clinical microbiology laboratory to investigate a community cluster of Shigella sonnei

Gordon Ritchie , Molecular Scientist, , Providence Health Care

Gordon Ritchie (Ph.D., DABCC, FNACB) is a Clinical Scientist at St. Paul’s Hospital in Vancouver, an...

picture of Aaron Pomerantz

Aaron Pomerantz, Associate Director, Segment Marketing - Infectious and Applied Markets, Oxford Nanopore Technologies

Aaron received his PhD from UC Berkeley in the Department of Integrative Biology, employing genomics...

picture of Kyriaki Xanthopoulou

Long-read sequencing to track plasmid transmissions; characterizing NDM-5-positive Escherichia coli clinical isolates from a German hospital

Kyriaki Xanthopoulou, Long-read sequencing to track plasmid transmissions; characterizing NDM-5-positive Escherichia coli clinical isolates from a German hospital, University of Cologne

Dr Xanthopoulou is a postdoctoral research fellow at the Institute of Medical Microbiology, Immunolo...